TP53 and neoplasm: However, during the 2-year follow-up period, significant differences were observed between the recurrence and non-recurrence groups in the maximum tumor diameter (p = 0.01), mean MAF of ctDNA variants (p = 0.04), number of ctDNA variants (p <0.001), and ctDNA TP53 mutation status (p = 0.01).